Eomesodermin is required for antitumor immunity mediated by 4-1BB-agonist immunotherapy
OncoImmunology Volume 3 Issue 2
Page e27680-
published_at 2014
Title
Eomesodermin is required for antitumor immunity mediated by 4-1BB-agonist immunotherapy
Creators
Song Chang
Creators
Sadashivaiah Kavitha
Creators
Furusawa Aki
Creators
Davila Eduardo
Creators
Banerjee Arnob
Languages
eng
Resource Type
journal article
Publishers
Landes Bioscience
Date Issued
2014
File Version
Not Applicable (or Unknown)
Access Rights
metadata only access
Relations
[ISSN]2162-402X
[PMID]info:pmid/24790793
[isVersionOf]
[URI]https://www.landesbioscience.com/journals/oncoimmunology/
Schools
大学院医学系研究科（医学）